FIORUCCI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 21.656
EU - Europa 12.696
AS - Asia 11.744
SA - Sud America 2.288
Continente sconosciuto - Info sul continente non disponibili 939
AF - Africa 338
OC - Oceania 17
Totale 49.678
Nazione #
US - Stati Uniti d'America 20.584
SG - Singapore 5.821
IE - Irlanda 2.057
UA - Ucraina 2.049
IT - Italia 1.834
RU - Federazione Russa 1.811
BR - Brasile 1.753
CN - Cina 1.523
SE - Svezia 1.483
HK - Hong Kong 1.294
VN - Vietnam 1.084
FR - Francia 785
DE - Germania 782
FI - Finlandia 659
GB - Regno Unito 482
CA - Canada 464
KR - Corea 368
IN - India 264
TR - Turchia 245
BD - Bangladesh 243
AR - Argentina 153
IQ - Iraq 136
MX - Messico 135
PL - Polonia 118
AT - Austria 100
CO - Colombia 98
ZA - Sudafrica 98
CH - Svizzera 92
NL - Olanda 92
PK - Pakistan 89
EC - Ecuador 86
ID - Indonesia 82
ES - Italia 81
VE - Venezuela 81
JP - Giappone 78
UZ - Uzbekistan 73
CR - Costa Rica 70
SA - Arabia Saudita 65
SV - El Salvador 59
PH - Filippine 56
GT - Guatemala 55
EE - Estonia 49
HN - Honduras 48
MA - Marocco 48
TT - Trinidad e Tobago 48
NI - Nicaragua 47
BE - Belgio 46
IL - Israele 44
JM - Giamaica 44
PR - Porto Rico 41
MY - Malesia 38
CZ - Repubblica Ceca 35
LB - Libano 35
PY - Paraguay 35
CW - ???statistics.table.value.countryCode.CW??? 33
GR - Grecia 31
CL - Cile 30
KE - Kenya 30
AE - Emirati Arabi Uniti 28
RO - Romania 25
TN - Tunisia 25
EG - Egitto 23
SC - Seychelles 22
PE - Perù 21
KZ - Kazakistan 19
LT - Lituania 18
UY - Uruguay 18
ET - Etiopia 17
EU - Europa 15
JO - Giordania 15
NP - Nepal 15
AZ - Azerbaigian 14
OM - Oman 14
TH - Thailandia 14
GP - Guadalupe 13
LY - Libia 13
PA - Panama 12
AU - Australia 11
BO - Bolivia 11
DZ - Algeria 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
RS - Serbia 10
AL - Albania 9
BG - Bulgaria 9
TW - Taiwan 9
BB - Barbados 8
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
AM - Armenia 7
SN - Senegal 7
GE - Georgia 6
KW - Kuwait 6
BN - Brunei Darussalam 5
BS - Bahamas 5
DK - Danimarca 5
HR - Croazia 5
IR - Iran 5
NG - Nigeria 5
PT - Portogallo 5
Totale 48.680
Città #
Singapore 4.146
Chandler 2.286
Dublin 2.044
San Jose 1.941
Ashburn 1.924
Hong Kong 1.291
San Mateo 1.228
Jacksonville 847
Santa Clara 827
Boardman 744
Council Bluffs 716
Moscow 634
Dong Ket 622
Princeton 549
Medford 548
Altamura 518
Wilmington 501
Lauterbourg 495
Lawrence 383
Beijing 347
Andover 345
Ann Arbor 341
Perugia 332
Des Moines 320
Seoul 291
Los Angeles 262
New York 239
São Paulo 214
The Dalles 188
Saint Petersburg 165
Ho Chi Minh City 153
Helsinki 131
Izmir 120
Dallas 118
Munich 117
Piscataway 116
Hanoi 100
Norwalk 96
Falls Church 95
Brooklyn 88
North Bergen 85
Ottawa 85
Columbus 83
Montreal 81
Phoenix 81
Toronto 79
Orem 75
Shanghai 73
Warsaw 73
Tokyo 70
Rome 68
Chicago 65
Woodbridge 64
Baghdad 63
Houston 61
Milan 59
San José 58
Frankfurt am Main 57
Rio de Janeiro 57
San Paolo di Civitate 57
Johannesburg 54
San Salvador 53
Chennai 51
Atlanta 50
London 50
Naples 50
Stockholm 47
Nuremberg 46
Turku 46
Managua 45
Brussels 44
Guatemala City 41
San Francisco 41
Mexico City 40
Amsterdam 39
Buffalo 39
Manchester 39
Vienna 38
Denver 37
Tashkent 37
Redwood City 35
Boston 34
Curitiba 34
Quito 34
Redmond 33
Dhaka 32
Seattle 31
Willemstad 31
Ankara 30
Philadelphia 29
Bogotá 28
Lahore 28
Brasília 27
Florence 27
Guayaquil 27
Poplar 27
Belo Horizonte 26
Charlotte 26
Auburn Hills 25
Den Haag 25
Totale 29.292
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 198
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 168
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 164
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 162
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 157
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 153
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 152
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 152
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 151
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 149
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 149
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 149
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 146
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 146
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 146
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 144
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 143
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 143
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 142
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 140
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 140
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 139
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 139
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 137
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 136
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 136
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 135
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 134
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 134
Antiatherosclerotic effect of farnesoid X receptor. 133
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 129
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 129
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 129
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 128
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 128
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 127
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 127
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 125
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 125
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 125
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 124
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 124
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 124
.The vagal control of gallbladder motility is impaired in diabetics with autonomic neuropathy. 124
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 124
A magic bullet for mucosal protection...and aspirin is the trigger! 124
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 123
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 123
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 122
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 121
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 121
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 120
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 120
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 120
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 119
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 119
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 119
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 118
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 118
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 118
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 118
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 118
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 118
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 118
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 117
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 117
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 117
Bile Acid Signaling in Inflammatory Bowel Diseases 117
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 116
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 116
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 116
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 116
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 116
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 116
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 116
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 115
Nitric oxide inhibits hepatic stellate cell dependent tumor angiogenesis in primary and metastatic liver cancer 115
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 115
Primary brain abscess with Nocardia farcinica in an immunocompetent patient 115
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 114
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 114
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 114
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 114
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 114
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 114
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 114
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 113
D-2-antagonist levosulpiride inhibits afferent mediating perception of gastric distention in functional dyspepsia. 112
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 112
NO-NSAIDs are ICE/caspase1 inhibitors and protect from citokine-mediated acute liver failure induced by Concanavalin A in mice. 111
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 110
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 110
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 109
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 109
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 109
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 109
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 109
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 108
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 108
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 108
Totale 12.661
Categoria #
all - tutte 232.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.115 0 0 0 0 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20256.875 69 695 224 227 902 284 247 602 1.423 456 1.066 680
2025/202614.534 1.059 898 860 1.698 1.799 1.247 2.610 769 1.709 1.233 407 245
2026/20275.417 359 465 869 3.306 418 0 0 0 0 0 0 0
Totale 49.678